Scientific research on the ageing brain
Over two decades of scientific research has led to the development of ReMind™ (known as Memory Health in the US). This unique food supplement reflects the very latest scientific understanding of brain nutrition and was most recently used in the innovative, double-blind, placebo-controlled, Re-MIND clinical trial at Nutrition Research Centre Ireland (NRCI), South East Technological University (SETU). This clinical trial was published in The Journal of Alzheimer’s Disease and was recognised as providing strong clinical evidence for the key role of nutritional supplementation in the management of Alzheimer’s disease.
Positive effects on brain function
The relationship between targeted nutrition and brain health is now well established, and even more important than ever because of our growing and ageing population.
ReMind™ contains protective active ingredients that are naturally found in the brain, but which decrease with age and disease. This unique formulation of carotenoids, omega-3 fatty acids and vitamin E has been proven to support normal brain function in healthy individuals, those with Mild Cognitive Impairment and patients with Alzheimer’s disease*. The results were published in the scientific Journal of Alzheimer’s Disease* as a breakthrough for long-term brain function.
Peer-reviewed and published evidence of effectiveness
The research studies that led to the development and testing of ReMind™ have been peer-reviewed by leading independent researchers in the field and have been published in esteemed titles such as the Journal of Alzheimer’s Disease and Nutrition. To learn even more why not read this Summary of the Evidence, written by Prof John Nolan, Director of Nutrition Research Centre Ireland.
Unique patented formula
The ReMind™ formula has received treatment patents from the United States, United Kingdom, and Ireland specifically for its role as an effective tool for improving and protecting brain function.